The Popularity of the Legal Cannabis Market Continues to Gain Globally

Wednesday, July 19, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+ News Commentary

NEW YORK, July 19, 2017 /PRNewswire/ --

According to a research report

published by the Arcview Group, the legal cannabis industry accelerated at a strong pace in 2016 and is expected to continue. The market research forecasts growth will reaccelerate beginning in 2018, as adult-use sales ramp up in Canada,
California and Massachusetts, along with medical sales in Florida. The market looks to grow from $6.7-billion in 2016 at a robust 27% CAGR to $22.6 billion in 2021. The report indicates that the 20+% annual growth rate is likely to continue for many years past 2021, as more states and countries legalize cannabis products. Marijuana Company of America, Inc. (OTC: MCOA), Medical Marijuana, Inc. (OTC: MJNA), MCig Inc. (OTC: MCIG), General Cannabis Corp. (OTC: CANN), United Cannabis Corporation (OTC: CNAB)

New Frontier Data recently published a report on the cannabis market and stated, "Cannabis stocks significantly outperformed major indexes in 2016, fueled by speculative investment based on anticipated expansion of new legal markets. In the run up to the election, stocks increased by 207.8% and continued to rise, even with an uncertain future under the new administration. While recent comments by the Trump administration did have an initial dampening effect on the market, we have seen continued growth relative to Q4 2016 whereby cannabis stocks are still outperforming other sectors," said Giadha Aguirre De Carcer, CEO of New Frontier Data.

Marijuana Company of America, Inc. (OTC: MCOA) just this morning announced that, "it has contributed the first installment of capital to Bougainville Ventures, Inc. ("BV") in partial satisfaction of the joint venture agreement entered into earlier this year in Washington State.

MCOA received $375,000 in its first round of financing. This investment will contribute to funding the development of a state-of-the-art 30,000 sq. ft. greenhouse grow facility in Oroville, Washington. Once completed, the greenhouse facility will accommodate a cannabis production and processing tenant with a Tier 3, I-502 license with significant experience growing cannabis. The total principal amount of the convertible note that MCOA executed with its financing partner is $752,500, with a 16 month term and 10% annual interest rate. Additional rounds of financing will be received as part of this note, which MCOA intends to invest in BV in satisfaction of the terms of its JV agreement.

As turnkey landlords, MCOA and BV look to provide an ideal cultivation environment that their current tenant can move into in Q3, and be fully operational and revenue producing in early Q4. As more states legalize the cultivation and consumption of cannabis, MCOA intends to replicate this business model and build the Company's real estate portfolio and increase its revenue.

Donald Steinberg, MCOA President and CEO, said, "I am very pleased that we obtained the financing to start our operations in Washington. We are projecting that this joint venture will soon be profitable and be a model that we can replicate in other states and countries. We are also happy to establish a relationship with a financing partner that is interested in supporting joint venture projects for MCOA in the future."

The closing of its first round of financing is a significant step in completing the Company's JV partnership that was formed to construct two greenhouses, provide management services and a commercial lease to an I-502 licensed grower in Washington State. Separately, the Company announced effective July 1, 2017, the establishment of a new corporate office located at 1320 West Valley Parkway, Escondido, California, 92029, that will include space for the Company's back office support team for its HempSMART brand, and provide office space for some Company executives.

Medical Marijuana, Inc. (OTC: MJNA), is the first-ever publicly traded cannabis company in the United States. The company recently announced that the second quarter of 2017 generated the largest revenue quarter in the Company's history. The Company saw a gross revenue increase from $1,660,633 in Q2 2016 to $6,131,415 in Q2 2017, a quarter-over-quarter increase of 269% making it the largest quarter in the Company's history. The Company also saw year-to-date and year-over-year revenue increase from $3,177,103 to $9,651,088 an increase of 203%. Medical Marijuana, Inc. CEO Dr. Stuart Titus said: "As a well-known Company of Firsts, we are encouraged to see the Company achieve a new milestone - hitting its highest revenue mark ever in this last financial quarter. We continue to work closely with our portfolio of companies to ensure their success, and look forward to breaking new records as we continue to expand our footprint in new markets."

MCig Inc. (OTCQB: MCIG) is a diversified and vertically integrated cannabis group committed to being the leading distributor of technology, products and services to fit the needs of the rapidly expanding cannabis sector. The company recently announced that the latest project updates for Grow Contractors (its construction and consulting division), in addition to the latest expansion of its cannabis supply division into the California cannabis market with record sales driven by recent recreational legalization in Nevada. Indicative of the marijuana shortage witnessed in Nevada as recreational use of cannabis went into effect, Grow Contractors is set to shatter previous sales record numbers. Furthermore, with its recent operations in taking on cultivation management contracts, MCIG has delivered on its game plan for cultivation and production ownership while mitigating risks through its consulting services.

General Cannabis Corp. (OTCQB: CANN) is the comprehensive resource for the highest quality service providers available to the regulated cannabis industry. Last month, the company announced the acquisition of GC Finance Arizona, LLC ("GC Arizona") from Infinity Capital West, LLC ("Infinity Capital").  GC Arizona owns two primary assets:  1) a 50% LLC membership interest in DB Products Arizona, LLC ("DB Arizona") and 2) a secured promissory note with DB Arizona in the amount of $825,000, plus accrued interest.  DB Arizona produces and distributes medical marijuana infused products in the state of Arizona.  The vast majority of DB Arizona's products to date have been Dixie Brands Inc.'s full line of medical cannabis "Dixie Elixirs and Edibles." 

United Cannabis Corporation (OTCQB: CNAB) has long advocated the application of cannabinoids for medical applications and is building a platform for designing targeted therapies to increase the quality of life for patients around the world. Recently, the company announced that Jamaica's Ministry of Health has registered its Prana P5 Hemp Bio Nutrient Capsules, Aromatherapy Roll-On and Sublingual Drops, and approved a Jamaican bilateral partner of the Company, Caribbean Research & Development Limited ("CRD"), to begin production in Jamaica. Through CRD, the Company now has approval in a legal market to research, cultivate, manufacture, and distribute its CBD-based products in Jamaica and reciprocal countries, giving United Cannabis and CRD immediate means to revenue. 

Please sign up now at To Receive Alerts on Trending Financial News from all these companies. "The Latest Buzz in Financial News"

Subscribe Now! Watch us report from NYSE

Follow us on Twitter for real time Financial News Updates:

Follow and talk to us on Instagram:

Facebook Like Us to receive live feeds:

About, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, creates 100% unique original content. also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on (the "Site") is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content),, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. has not been compensated directly by any of the companies mentioned here in this editorial. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. receives fees for producing and presenting high quality and sophisticated content on along with other financial news PR media services. does not offer any personal opinions or bias commentary as we purely incorporate public market information along with financial and corporate news. only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For this release, has been compensated four thousand dollars for financial news dissemination and pr services by a third party non affiliate for marijuana company of america, Inc. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. will always disclose any compensation in securities or cash payments for financial news PR advertising. does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security., members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit:

For further information: Media Contact: , +1-877-601-1879


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store